70 studies found for:    Narcolepsy
Show Display Options
RSS Create an RSS feed from your search for:
Narcolepsy
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Safety and Effectiveness Study of a Single Dose of JNJ-17216498 in Patients With Narcolepsy
Condition: Narcolepsy
Interventions: Drug: JNJ-17216498;   Drug: Modafinil
2 Completed PROVIGIL® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy or Obstructive Sleep Apnea/Hypopnea Syndrome
Conditions: Narcolepsy;   Sleep Apnea, Obstructive
Intervention: Drug: Modafinil
3 Completed Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.
Condition: Treatment of Excessive Daytime Sleepiness in Narcolepsy.
Interventions: Drug: BF2.649;   Drug: Vigil;   Drug: palcebo
4 Completed Study of PROVIGIL ® (Modafinil) Treatment in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Condition: Narcolepsy
Intervention: Drug: Modafinil
5 Completed
Has Results
Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy
Condition: Narcolepsy
Interventions: Drug: Xyrem;   Drug: Xyrem Placebo;   Drug: Modafinil at established dose;   Drug: Modafinil (Placebo)
6 Completed
Has Results
A Study of the Safety and Effectiveness of ADX-N05 for Excessive Daytime Sleepiness in Subjects With Narcolepsy
Condition: Narcolepsy
Interventions: Drug: ADX-N05;   Drug: Placebo
7 Unknown  Risk of Narcolepsy Associated With Administration of H1N1 Vaccine
Condition: Narcolepsy
Intervention: Other: No intervention
8 Completed Body Weight Regulation in Patients With Narcolepsy
Condition: Narcolepsy
Intervention:
9 Completed
Has Results
Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With Narcolepsy
Condition: Narcolepsy
Interventions: Drug: Armodafinil;   Drug: Placebo
10 Completed
Has Results
A Study Of A Novel Compound For Excessive Daytime Sleepiness Associated With Narcolepsy
Conditions: Excessive Daytime Sleepiness;   Narcolepsy
Interventions: Drug: Placebo;   Drug: PF-03654746
11 Terminated Effectiveness Of The Drug GSK189254 In Treating Patients With Narcolepsy
Condition: Narcolepsy
Intervention: Drug: GSK189254
12 Completed
Has Results
Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep Disorder
Conditions: Narcolepsy;   Sleep Apnea, Obstructive;   Sleep Apnea Syndromes;   Shift-Work Sleep Disorder
Intervention: Drug: CEP-10953 (Armodafinil)
13 Recruiting Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Armodafinil in Children and Adolescents With Excessive Sleepiness Associated With Narcolepsy
Condition: Narcolepsy
Intervention: Drug: Armodafinil
14 Completed
Has Results
Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness
Conditions: Excessive Daytime Sleepiness;   Narcolepsy;   Obstructive Sleep Apnea/Hypopnea Syndrome;   Chronic Shift Work Sleep Disorder
Intervention: Drug: Armodafinil 100 to 250 mg/day
15 Completed
Has Results
Trial of Xyrem® (Sodium Oxybate) for the Treatment of Narcolepsy
Condition: Narcolepsy
Intervention: Drug: Xyrem (sodium oxybate) oral solution
16 Active, not recruiting Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant)
Conditions: Narcolepsy;   Cataplexy
Intervention: Drug: BF2.649
17 Completed Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy
Conditions: Narcolepsy;   Excessive Daytime Sleepiness;   Cataplexy;   Sleep Disorders
Interventions: Drug: BF2.649;   Drug: Modafinil;   Drug: Placebo
18 Completed Safety and Efficacy of Xyrem Oral Solution (Sodium Oxybate) Compared With Placebo in Narcoleptic Patients
Condition: Narcolepsy
Intervention: Drug: sodium oxybate
19 Recruiting A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy
Condition: Narcolepsy With Cataplexy
Intervention: Drug: Xyrem
20 Completed A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness
Condition: Narcolepsy
Interventions: Drug: ADX-N05;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years